Rights and permissions
About this article
Cite this article
Capecitabine, oxaliplatin acceptable adjuvant option to NHS. Inpharma Wkly. 1575, 5 (2007). https://doi.org/10.2165/00128413-200715750-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715750-00010